Konica Minolta : Presentation Slides for Q4/March 2026 Consolidated Financial Results

Published May 14, 2026 at 6:44 a.m. UTC

Source: MarketScreener

Konica Minolta, Inc. FY2025 ended in March 2026 Consolidated Financial Results Toshimitsu Taiko President and CEO, Representative Executive Officer May 14, 2026

FY2025 PERFORMANCE OVERVIEW

FY2025 Performance | Summary

Compared to FY24

Revenue Decreased (+: FOREX and revenue increase in Industry, －: business selection and concentration, and lower revenue
in office and healthcare)
Business contribution profit
Increased (+: improvement in gross profit ratio due to an improved business mix, improvement in SG&A expenses ratio from global structural reform efforts and other initiatives, and absence of decrease by correction of elimination of unrealized gains in consolidated adjustments; impact of U.S. tariffs was -¥5.3 billion)
Operating profit Increased (+: absence of one-time expenses recorded in the previous fiscal year, including structural reform costs, expenses related to business selection and concentration, and impairment losses)
Profit attributable to owners of the Company
Increased (+: improvement in finance income and costs, improvement in tax rates including one-time factors, and valuation loss on Tempus AI shares)
FCF Decreased (+: operating cash flows due to higher profit before tax; －: investing cash flows due to lower cash inflows from business transfers and higher cash inflows from partial sale of Tempus AI shares)

[¥ billions]

FY24 12M

FY25 12M

YoY

w/o FOREX

FY24 Q4

FY25 Q4

YoY

w/o FOREX

Revenue 1,127.9

Gross Profit 479.4

Gross Profit ratio 42.5%

SG＆A 447.5

SG＆A ratio 39.7%

Business Contribution Profit*1 31.9

Business Contribution Profit ratio 2.8%

Operating Profit -64.0

Profit attributable to owners of the Company -47.5*

FCF 75.7*

1,087.7

478.4

44.0%

425.2

39.1%

53.2

4.9%

49.9

2 30.3

2 52.3

-4% -5% 296.0

-0% -2% 115.1

+1.5pt 38.9%

-5% -6% 112.0

-0.6pt 37.8%

+67% +55% 3.1

+2.1pt 1.1%

- - -45.6

- -34.1

-31% 69.0

306.6

131.8

43.0%

113.3

36.9%

18.5

6.0%

16.6

8.8

27.4

+4% -2%

+14% +6%

+4.1pt

+1% -4%

-0.9pt

+492% +389%

+5.0pt

- -

-60%

FOREX

[Yen]

150.77

174.79

-1.81 152.60

+11.04 160.50

156.86

183.65

+4.26

+23.15

USD EUR

152.58

163.75

*1 Business contribution profit: The profit subtracted sales cost, SG&A from revenue

*2 Including those from discontinued businesses

FY2025 Performance | Increase/Decrease Factors of PL

[¥ billions]

	FY24 12M	FY25 12M	Increase/ Decrease	Main factors of increase/decrease
Revenue	1,127.9	1,087.7	-40.1 Business selection and concentration*1: -51.0, and FOREX: +16.2, etc.
Gross profit	479.4	478.4	Business selection and concentration*1: -12.3, U.S. tariff expenses and related impacts on sales: -1.0 -12.2, FOREX: +10.1, and absence of decrease by correction of elimination of unrealized gains in consolidated adjustments recorded in FY24: +11.4, etc.
SG&A	447.5	425.2	-22.3 Structural reform efforts: -13.0, business selection and concentration*1: -14.5, cost reductions from measures in response to U.S. tariffs : -6.9, FOREX: +6.4, and others: +6.0, etc.)
Business contribution profit	31.9	53.2	+21.3

Capital expenditures*2 41.6

60.5

+18.9 Acquisition of real estate trust beneficiary interests in the land of Tokyo Site Hino: +18.9

Depreciation and 52.8

amortization expenses*3

40.2

-12.6 Business selection and concentration*1: -8.3, and absence of impairment losses of property, plant and equipment and others recorded in FY24: -2.7, etc.

Research and development 59.6

expenses

54.8

-4.8 Business selection and concentration*1: -2.0, etc.

*1 Business transfers in DW-DX, marketing services, and imaging IoT solutions unit. Precision Medicine Business is not included as it is a discontinued operation

*2 Including the expenses for acquiring real estate trust beneficiary interests in the land of Tokyo Site Hino (¥18.9 billion)

*3 Not including IFRS16 right-of-use assets amortization expenses

FY2025 Performance | Increase/Decrease Factors of PL

[¥ billions]

	FY24 12M	FY25 12M	Increase/ Decrease	Main factors of increase and decrease
Other income and expenses	-95.9	-3.3	+92.6 Absence of one-time expenses recorded in FY24, including impairment losses +51.1, structural reform costs +21.6, and expenses related to business selection and concentration*1 +19.6
Operating profit	-64.0	49.9	+113.9
Financial income and costs	-15.1	-6.5	+8.7 Decrease in interest payments, including lease interest +0.9, gains on the acquisition of real estate trust beneficiary interests in the land of Tokyo Site Hino +1.1, and FOREX: +6.0
Profit before tax	-79.2	43.4	+122.6
Income tax expense	-16.2	-9.6	Improvement in tax expense for the current fiscal year caused by an improvement in the +6.6 recoverability of deferred tax assets related to tax losses incurred in connection with the business selection and concentration promoted in the previous fiscal year, including one-time factors ,etc.
Profit from continuing operations	-95.4	33.8	+129.2
Profit from discontinued operations	45.1	-1.9	-47.0 Valuation gains on Tempus AI shares and losses on partial sale of shares -1.7, and absence of gains on the sale of Ambry Genetics Corporation and others in FY24.: -45.1
Profit attributable to	-50.3	31.8	+82.2
Owners of the Company	-47.5	30.3	+77.8
Non-controlling -2.8 interests		1.6	+4.4 Absence of impairment losses related to MGI in FY24 : +4.2

*1 Business transfers in DW-DX, marketing services, and imaging IoT solutions unit. Precision Medicine Business is not included as it is a discontinued operation © KONICA MINOLTA 5